CRNS and the Institut Pasteur conducted research in France on patients diagnosed with cryptococcosis which ranks second among fatal opportunistic infections in patients infected by HIV and who are profoundly immunosuppressed.
To help physicians non-invasively identify women at risk for preterm birth, 3-D ultrasound was used to measure the size of fetal adrenal glands, according to an abstract presented by Yale School of Medicine researchers at the Society for Maternal-Fetal Medicine Conference February 8 in San Francisco.
Lower transplant rates in ethnic communities may be explained somewhat by a lack of suitable anonymous donors, a problem the medical community has long known and been working to address.
Researchers at the 27th Annual Society for Maternal-Fetal Medicine (SMFM) meeting announced today that high-dose progesterone treatment helped at-risk pregnant women avoid premature delivery.
Cigarette pack warning labels with prominent text and graphic pictures of smoking damage are most effective at changing smokers’ behavior.
A team from the University of Western Sydney’s Centre for Complementary Medicine Research (CompleMED) is working with the Cardiac Health Institute to find out if the medicinal mushroom, Ganoderma lucidum, can reduce high blood sugar, often a precursor to diabetes – as well as treat other health problems.
A new treatment for psoriasis that targets its key inflammatory mediators (IL-12 and IL-23) is highly effective, according to a study by University of Utah researchers to be published in the Feb. 8 issue of The New England Journal of Medicine.
Many physicians feel no obligation to tell patients about legal but morally controversial medical treatments or to refer patients to doctors who do not object to those treatments, report researchers from the University of Chicago in the Feb. 8, 2007, issue of the New England Journal of Medicine.
Physicians who treat a blood disorder called idiopathic thrombocytopenic purpura (ITP), characterized by easy bruising and excessive bleeding, now have a new tool to help them provide the best care for patients with this disease.
People who receive implantable cardioverter defibrillators (ICD) as a preventative measure don?t need the same driving restrictions as people who get an ICD after surviving a life-threatening heart rhythm disturbance.